• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
79,273.33 753.03
( 0.96%)
Global Indices
Nasdaq
49,464.98 -3.46
(-0.01%)
Dow Jones
7,130.75 -16.31
(-0.23%)
Hang Seng
59,361.39 536.50
(0.91%)
Nikkei 225
10,604.22 -63.41
(-0.59%)
Forex
USD-INR
92.58 -0.61
(-0.65%)
EUR-INR
108.87 -0.98
(-0.89%)
GBP-INR
125.07 -1.17
(-0.93%)
JPY-INR
0.58 0.00
(-0.45%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
17.34
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
246.67
56.43
EPS(TTM)
Face Value()
Div & Yield %
0.15
10
0
 

abate as industries ltd
RBI grants approval to ICICI AMC for acquisition of upto 9.95% stake in Karur Vysya Bank
Feb 13,2026
Karur Vysya Bank announced that the Reserve Bank of India (RBI) vide its letter dated 10 February 2026, has accorded its approval to ICICI Prudential Asset Management Company (ICICI AMC), along with group entities of ICICI Bank, for acquiring aggregate holding of up to 9.95% of the paid-up share capital or voting rights of Karur Vysya Bank. The approval has been granted with reference to the application made by ICICI AMC to RBI.